• Vertex ceases development of VX-522 inhaled RNA therapy for CF after stopping Phase 1/2 trial due to tolerability issues

  Vertex has stopped a Phase 1/2 study of VX-522 inhaled RNA therapy for the treatment of cystic fibrosis and has ceased development of the product, the company said in its most recent report of financial… [Read more . . .]

• Enterprise Therapeutics says Phase 2 trial of ETD001 inhaled ENaC blocker for CF met its primary endpoint

  Enterprise Therapeutics announced that a Phase 2 trial of ETD001, an inhaled epithelial sodium channel blocker, met its primary endpoint, demonstrating a statistically significant and clinically relevant improvement in lung function versus placebo after 28… [Read more . . .]

• Chance Pharma reports NMPA acceptance of NDA for CXG87 budesonide / formoterol DPI, Phase 3 results

  According to Chance Pharmaceuticals, China’s National Medical Products Administration has accepted the company’s NDA for CXG87 budesonide / formoterol DPI for the treatment of asthma. The announcement emphasizes that the formulation is Chance’s own “improved… [Read more . . .]

• Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

  CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing… [Read more . . .]

• Intertek announces expansion of GMP stability storage facility

  CDMO Intertek has announced an expansion of a GMP stability storage facility near Cambridge, UK, noting that the expanded facility offers custom temperature and relative humidity conditions and is suitable for stability testing of a… [Read more . . .]

• RDD 2026 exhibitor preview

• MannKind is developing ralinepag DPI (MNKD-1501) for United Therapeutics

• Merxin receives King’s Award for Enterprise, names new Head of Business Development

• Copley Scientific introduces new SRS 100i sample recovery system for inhaler testing

• 3P Innovation and Mikron Automation partner to offer DPI manufacturing systems

More news . . .